Tracer library / [68Ga]Ga-DOTA-Z09591

[68Ga]Ga-DOTA-Z09591

Also written as [68Ga]Ga-ATH001; [68Ga]Ga-DOTA-Z09591; [Ga-68]Ga-DOTA-Z09591
Radionuclide
Ga-68 t½ 67.71 min
Modality
PET
Production route
—
Stage
Clinical research
Syntheses indexed
0

What it is

Compound class
Affibody molecule (DOTA-conjugated Cys-ATH001)
Target / mechanism
Platelet-derived growth factor receptor beta (PDGFRβ) PMID 41471324
Clinical application
PET imaging of PDGFRβ-expressing fibrotic remodeling in post-infarction myocardium PMID 41471324
Theranostic pair
—

Published syntheses

No synthesis has been parsed for this agent yet.

Clinical literature

Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.

  1. Ga-68-Labeled Affibody Molecule-Based Radiopharmaceutical Targeting Platelet Derived Growth Factor Receptor Beta for Detection of Active Fibrosis in Patients with Myocardial Infarction.
    2025 · Pharmaceuticals (Basel) · Clinical study · Phase 0

Need this precursor?We can point you to suppliers for [68Ga]Ga-DOTA-Z09591, or handle the enquiry for you.

Get in touch

Quality control Preliminary - inferred from compound class

Ph. Eur. monograph
not verified No Ph. Eur. check is recorded for this entry.
USP monograph
not verified No USP check is recorded for this entry.
AppearancepHRCP HPLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrityMolar activityMetal impuritiesGe-68 breakthrough
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); radiometal tracer -> metal impurities (rule); Ga-68, generator production assumed (no synthesis data found) -> Ge-68 breakthrough (preliminary); receptor ligand with a saturable target -> molar activity (rule)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [68Ga]Ga-DOTA-Z09591.

Get in touch

Notes

Added from reverse module search (stage 6); 1 article(s) with Ga-68. Compound class inferred from precursor name (not stated outright) -- PMID 41471324: 'DOTA-Cys-ATH001'. Stage set/updated at stage 23 from PMID 41471324: '[68Ga]Ga-ATH001 was successfully developed and validated for phase 0 clinical study.'. | Stage 30 (2026-09-18): Stage was 'phase 0 clinical study'; normalised to 'Clinical research', original wording kept here.
Ask a question